This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Carol Lewis, MPH, ScD; Thomas A. Pearson, MD, PhD
The Mary Imogene Bassett Hospital Research Institute Cooperstown, NY

Arlene W. Caggiula, DrPH, RD
University of Pittsburgh (Pa)

Patricia Elmer, PhD, RD
University of Minnesota Minneapolis

Ross Simpson, Jr, MD
University of North Carolina at Chapel Hill

JAMA. 1993;270(8):936-937.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We are investigators for the National Heart, Lung, and Blood Institute-funded demonstration project Assisting Primary Care Physicians With Lipid-Lowering Interventions (APPLI); we and our APPLI colleagues are concerned about the recent article by Hulley et al.¹ (The APPLI is studying the application of current cholesterol treatment guidelines in routine community practice.) Hulley et al question whether we should be measuring blood cholesterol levels in men younger than 35 years and women younger than 45 years, as has been recommended by the National Cholesterol Education Program Adult Treatment Panel.² They argue that (1) cholesterol intervention in low-risk adults is not cost-effective and may cause more harm than benefit, and (2) intervention in middle age can prevent CHD. They dismiss dietary treatment as ineffective and unacceptable.

The Population Panel of the National Cholesterol Education Program does not emphasize cholesterol screening to identify high-risk persons—the focus of Hulley . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?